Cargando…

Dosimetric Uncertainties in Dominant Intraprostatic Lesion Simultaneous Boost Using Intensity Modulated Proton Therapy

PURPOSE: While intensity modulated proton therapy can deliver simultaneous integrated boost (SIB) to the dominant intraprostatic lesion (DIL) with high precision, it is sensitive to anatomic changes. We investigated the dosimetric effects from these changes based on pretreatment cone-beam computed t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhou, Jun, Yang, Xiaofeng, Chang, Chih-Wei, Tian, Sibo, Wang, Tonghe, Lin, Liyong, Wang, Yinan, Janopaul-Naylor, James Robert, Patel, Pretesh, Demoor, John D., Bohannon, Duncan, Stanforth, Alex, Eaton, Bree, McDonald, Mark W., Liu, Tian, Patel, Sagar Anil
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2021
Materias:	Scientific Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8581277/ https://www.ncbi.nlm.nih.gov/pubmed/34805623 http://dx.doi.org/10.1016/j.adro.2021.100826

Ejemplares similares

Dosimetric Evaluation of PSMA PET-Delineated Dominant Intraprostatic Lesion Simultaneous Infield Boosts
por: Goodman, Christopher D., et al.
Publicado: (2019)

Onboard cone‐beam CT‐based replan evaluation for head and neck proton therapy
por: Stanforth, Alexander, et al.
Publicado: (2022)

Simultaneous integrated boost with stereotactic radiotherapy for dominant intraprostatic lesion of localized prostate cancer: a dosimetric planning study
por: Kim, Yeon Joo, et al.
Publicado: (2020)

MRI-based Treatment Planning for Proton Radiotherapy: Dosimetric Validation of a Deep Learning-based Liver Synthetic CT Generation Method
por: Liu, Yingzi, et al.
Publicado: (2019)

Feasibility of biology-guided radiotherapy using PSMA-PET to boost to dominant intraprostatic tumour
por: Gaudreault, Mathieu, et al.
Publicado: (2022)

Longitudinal Changes in U.S. Parameters of Neurovascular Bundles Suggest Mechanism for Radiation-Induced Erectile Dysfunction
por: Janopaul-Naylor, James R., et al.
Publicado: (2022)

Dosimetric impact of intrafraction motion on boosts on intraprostatic lesions: a simulation based on actual motion data from real time ultrasound tracking
por: Ballhausen, Hendrik, et al.
Publicado: (2019)

MRS-guided HDR brachytherapy boost to the dominant intraprostatic lesion in high risk localised prostate cancer
por: Kazi, Aleksandra, et al.
Publicado: (2010)

Impact of multileaf collimator width on intraprostatic dose painting plans for dominant intraprostatic lesion of prostate cancer
por: Abe, Eisuke, et al.
Publicado: (2010)

Inter-fraction deformable image registration using unsupervised deep learning for CBCT-guided abdominal radiotherapy
por: Xie, Huiqiao, et al.
Publicado: (2023)

Deep learning-based Fast Volumetric Image Generation for Image-guided Proton FLASH Radiotherapy
por: Chang, Chih-Wei, et al.
Publicado: (2023)

Virtual Away Rotations Increase Access to Radiation Oncology
por: Janopaul-Naylor, James, et al.
Publicado: (2021)

Early in vivo Radiation Damage Quantification for Pediatric Craniospinal Irradiation Using Longitudinal MRI for Intensity Modulated Proton Therapy
por: Chang, Chih-Wei, et al.
Publicado: (2023)

Determination of Intraprostatic and Intratesticular Androgens
por: Šimková, Markéta, et al.
Publicado: (2021)

Rapid unpaired CBCT‐based synthetic CT for CBCT‐guided adaptive radiotherapy
por: Wynne, Jacob F., et al.
Publicado: (2023)

Volumetric and Voxel-Wise Analysis of Dominant Intraprostatic Lesions on Multiparametric MRI
por: Lee, Joon, et al.
Publicado: (2019)

Radiation Facility Volume and Survival for Men With Very High-Risk Prostate Cancer Treated with Radiation and Androgen Deprivation Therapy
por: Sebastian, Nikhil, et al.
Publicado: (2023)

Intraprostatic Hydatid Cyst: An Unusual Presentation
por: Nouira, Yassine, et al.
Publicado: (2006)

Volumetry of the dominant intraprostatic tumour lesion: intersequence and interobserver differences on multiparametric MRI
por: Harvey, Hugh, et al.
Publicado: (2017)

The Intraprostatic Immune Environment after Stereotactic Body Radiotherapy is Dominated by Myeloid Cells
por: Nickols, Nicholas G., et al.
Publicado: (2020)

The Role of Intraprostatic Inflammation in the Acute Urinary Retention
por: Asgari, Seyed Alaeddin, et al.
Publicado: (2011)

Quantification of the margin required for treating intraprostatic lesions
por: Studenski, Matthew T., et al.
Publicado: (2016)

Feasibility and safety of definite volumetric modulated arc therapy with simultaneous integrated boost to the dominant intraprostatic lesion in patients with unfavorable intermediate to high-risk prostate cancer
por: Dankulchai, Pittaya, et al.
Publicado: (2022)

A topology-based method to mitigate the dosimetric uncertainty caused by the positional variation of the boost volume in breast conservative radiotherapy
por: Lee, Peng-Yi, et al.
Publicado: (2017)

Prostate irradiation with focal dose escalation to the intraprostatic dominant nodule: a systematic review
por: Feutren, Thomas, et al.
Publicado: (2018)

Radiotherapy planning in a prostate cancer phantom model with intraprostatic dominant lesions using stereotactic body radiotherapy with volumetric modulated arcs and a simultaneous integrated boost
por: Skrobala, Agnieszka, et al.
Publicado: (2023)

Prediction and Mapping of Intraprostatic Tumor Extent with Artificial Intelligence
por: Priester, Alan, et al.
Publicado: (2023)

Evaluation of measures related to dosimetric uncertainty of VMAT plans
por: Götstedt, Julia, et al.
Publicado: (2022)

Prostate Stereotactic Ablative Radiation Therapy Using Volumetric Modulated Arc Therapy to Dominant Intraprostatic Lesions()
por: Murray, Louise J., et al.
Publicado: (2014)

Phase I study of dose escalation to dominant intraprostatic lesions using high-dose-rate brachytherapy
por: Chapman, Christopher H, et al.
Publicado: (2018)

The Effect of Intraprostatic Chronic Inflammation on Benign Prostatic Hyperplasia Treatment
por: Kwon, Young Kee, et al.
Publicado: (2010)

Intraprostatic Botulinum Toxin injection in patients with benign prostatic enlargement
por: Ilie, CP, et al.
Publicado: (2009)

Disparities in time to prostate cancer treatment initiation before and after the Affordable Care Act
por: Janopaul‐Naylor, James R., et al.
Publicado: (2023)

Dosimetric impact of range uncertainty in passive scattering proton therapy
por: Liu, Ruirui, et al.
Publicado: (2021)

Evaluation of Dose-Painting in the Dominant Intraprostatic Lesions by Radiobiological Parameters using (68)Ga- PSMA PET/CT
por: Bamneshin, Khadijeh, et al.
Publicado: (2022)

Dosimetric Feasibility of Dose Escalation Using SBRT Boost for Stage III Non-Small Cell Lung Cancer
por: Hepel, Jaroslaw T., et al.
Publicado: (2012)

Midline intraprostatic cyst: An unusual cause of lower urinary tract symptoms
por: Nayyar, Rishi, et al.
Publicado: (2008)

Stereological comparison of intraprostatic injection of alcohol and bleomycin with finasteride gavages in rats
por: Eslahi, Ali, et al.
Publicado: (2017)

Geometric and dosimetric uncertainties in intracranial stereotatctic treatments for multiple nonisocentric lesions
por: Winey, Brian, et al.
Publicado: (2014)

Landmark tracking in liver US images using cascade convolutional neural networks with long short-term memory
por: Zhang, Yupei, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_3vomp9qln5mtp33bgq7p0fg8pu